Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving virus or bacteriophage
Patent
1998-11-12
2000-08-29
Salimi, Ali
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving virus or bacteriophage
435 721, 435 698, 435 79, 4353201, 4352351, C12G 170, G01N 33567, C12P 2104, C12N 1500
Patent
active
061106631
ABSTRACT:
Expression vectors that include reporter genes and an operable regulatory region containing a promoter and E2 binding sites of papillomavirus (PV), are used to detect and/or titer papillomavirus by quantitative or qualitative methods.
REFERENCES:
patent: 4983728 (1991-01-01), Herzog et al.
patent: 5364758 (1994-11-01), Meijer et al.
patent: 5484699 (1996-01-01), Bouma et al.
patent: 5770384 (1998-06-01), Androphy et al.
Thierry, F., et al. (1990) "Cooperative activation of transcription by bovine papillomavirus type 1 E2 can occur over a large distance." Mol. Cell. Biol. 10: 4431-4437.
Thierry, F. and M. Yaniv. (1987) "The BPV1-E2 trans-acting protein can be either an activator of a repressor of the HPV 18 regulatory region." EMBO J., 6: 3391-3397.
Ushikai, M., et al. (1994) "Trans activation by the full-length E2 proteins of human papillomavirus type 16 and bovine papillomavirus type1 in vitro and in vivo: cooperation with activation domains of cellular transcription factors." J. Virol. 68: 6655-6666.
Ustav, M. and A. Stenlund. (1991) "Transient replication of BPV-1 requires two viral polypeptides encoded by the E1 and E2 open reading frames." EMBO J. 10: 449-457.
Wasylyk, B., et al. (1984) "A novel eukaryotic promoter element: the simian virus 40 72 base pair repeat." Fed. Proc. 43 (2): 226-234.
Zhou, J., et al. (1995) "Early phase in the infection of cultured cells with papillomavirus virions." Virology. 214: 167-176.
Zur Hausen, H. and A. Schneider. (1987) "The role of papillomaviruses in human anogenital cancer." The Papovaviridae, vol. 2: The papillomaviruses. Plenum Press, New York.
Androphy, E.J. et al. (1987) "Bovine papillomavirus E2 trans-activating gene product binds to specific sites in papillomavirus DNA". Nature (London). 325: 70-73.
Angell et al. (1992) "An in vitro system for studying the initial stages of cottontail rabbit papillomavirus infection." J. Virol. Meth. 39: 207-216.
Berg, M. and A. Stenlund. (1997) "Functional interactions between papillomavirus E1 and E2 proteins." J. Virol. 71: 3853-8363.
Bouvard, V.A. et al. (1994) "Characterization of the human papillomavirus E2 protein: evidence of trans-activation and trans-repression in cervical keratinocytes." EMBO J. 13: 5451-5459.
Butel, J.S. et al. (1972) "Studies with human papillomavirus modeled after known papovavirus systems." J. Natl. Cancer Inst. 48: 285-299.
Christensen, N.D. and J.W. Kreider. (1990) "Antibody-mediated neutralization in vivo of infectious papillomaviruses." J. Virol. 64: 3151-3156.
Del Vecchio, A.M. et al. (1992) "Transient replication of human papillomavirus DNAs." J. Virol. 66: 5949-5958.
Dvoretzky, R.S. et al. (1980) "A quantative in vitro focus assay for bovine papilloma virus." Virol. 103: 369-375.
Hawley-Nelson, P. et al. (1988) "The specific DNA recognition sequence of the bovine papillomavirus E2 protein is an E2 dependent enhancer." EMBO J. 7: 525-531.
Hirochika, H. et al. (1987) "Enhancers and trans-acting E2 transcriptional factors of papillomaviruses." J. Virol. 61: 2599-2606.
Kovelman, R. et al. (1996) "Enahanced transcriptional activation by E2 proteins from the oncogenic human papillomaviruses." J. Virol. 70: 7549-7560.
Lambert, P.F. (1991) "Papillomavirus DNA replication (mini-review)." J. Virol. 65: 3117-3420.
Lancaster, W.D. and W. Meinke.(1975) "Persistence of viral DNA in human cell cultures infected with human papillomavirus." Nature (London). 256: 434-436.
Lancaster, W.D. and C. Olson. (1982) "Animal Papillomaviruses." Microbiol. Rev. 46: 191-207.
Meyers, C.M. (1996) "Organotypic (raft) epithelial tissue culture system for the differentiation dependent replication of papillomavirus." Meth. in Cell Sci. 18: 201-210.
Meyers, C.M., et al. (1992) "Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation." Science. 257: 971-973.
Meyers, C.M., et al. (1994) "Tissue culture techniques for the study of human papillomaviruses in stratified epithelia." A Laboratory Handbook. Academic Press, Inc.
Meyers, C. M., et al. (1997) "Synthesis of infectious human papillomavirus type 18 in differentiating epithelium transfected with viral DNA." J. Virol. 71: 7381-7386.
Moskaluk, C. and D. Bastia. (1987) "DNA bending is induced in an enhancer by the DNA-binding domain of the bovine papillomavirus E2 protein." Proc. Natl. Acad. Sci. 85: 1826-1830.
Ozbun, M.A. and C.M. Meyers. (1996) "Transforming growth factor .beta.1 induces differentiation in human papillomavirus-positive keratinocytes." J. Virol. 70: 5437-5446.
Pfister, H. (1984) "Biology and biochemistry of papillomaviruses." Rev. Physiol. Biochem. Pharmacol. 99: 111-181.
Roizman, B. (1990) "Multiplication of viruses: an overview." Virology: Second Edition. Raven Press, New York. pp. 87-94.
Smith, L.H., et al. (1993) "In vitro HPV-11 infection of human foreskin." Journal of Investigative Dermatology. 10: 438-444.
Smith, L.H., et al. (1995) "Titration of HPV-11 infectivity and antibody neutralization can be measured in vitro." Journal of Investigative Dermatology. 105: 438-444.
Spalholz, B.A., et al. (1988) "Evidence for cooperativity between E2 binding sites in E2 trans-regulation of bovine papillomavirus type 1." J. Virol. 62: 3143-3150.
Steinberg, B.M., et al. (1989) "Tissue site-specific enhancer function of the upstream regulatory region of human papillomavirus type 11 in cultured keratinocytes." J. Virol. 63: 957-960.
Sverdrup, F. and S.A. Kahn. (1995) "Two E2 binding sites alone are sufficient to function as the minimal origin of replication of human papillomavirus type 18 DNA." J. Virol. 69: 1319-1323.
Meyers Craig M.
Ozbun Michelle A.
Monahan Thomas J.
Salimi Ali
The Penn State Research Foundation
LandOfFree
Methods for detecting, titering, and determining susceptibility does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for detecting, titering, and determining susceptibility , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for detecting, titering, and determining susceptibility will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1248251